Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
We have a wall at $11.60. We break that we blow past $12?
Insiders can self fund this company today. They simply are choosing not to and that should make everyone wonder why.
PS.. stop the nonsense with the pity party for the Insiders, who have profited well over hundreds of millions of dollars of free shares off the backs of its Shareholders.
Your posts are false hood theories and misleading garbage. You have been wrong 100% of the time and my frustration towards the people responsible for this potential fraud has been 100% accurate. Follow the PPS as it never lies !!
Ihub should be and is the least of our concerns. You complain about ihub but not the destruction of HGEN caused by mismanagement
Share Structure
Market Cap Market Cap
1,655,214
07/27/2023
Authorized Shares
250,000,000
09/29/2020
Outstanding Shares
119,080,135
11/09/2022
Insanity
We have been LIED to by management!!
Hello!!!!
Hahahahahahaha. Remember those idiotic statements. The most recent one was 8 billion market cap
Sounds good!! The problem is the garbage management team that is responsible for this destruction to shareholders.
Stupid is an understatement. I’m the idiot of HGEN for over buying and others are for their worthless theories!! Total everything to a penny per share.
Unable to buy on many trading platforms!! Great job management!!
We are running!! Just ask CJ!!!
That’s somehow great news !! Just ask CJ!!
Insane is an understatement. LOL
Yesterdays news !!
Do we have a New symbol?
That’s would be a blessing BUT management has show zero capabilities
Three board members have also resigned, taking it below the minimum needed to stay on the main exchange, and it has now informed the Nasdaq it is unlikely to come back into compliance.
Imagine what we don’t know?
In its last financial statement, released at the end of March, the company was down to just over $3 million in cash reserves from around $10 million at the end of 2022, and it is now exploring the potential sale of its remaining assets in a bankruptcy proceeding that could “result in a complete or substantial loss of value” for its shareholders.
What did these idiots spend 7 million on in 3 months? Smells fishy !!
Is it a company representative or associate? What company? What representative ? They have no investor relations department and zero employees? Wake up!!!
Just think if we simply delisted without the potential ‘bankruptcy’ option via 8k we would probably still be trading over 20 cents with zero immediate pressure to trade above a 35 million MC. Management would then have time to restructure and or raise capital thru it’s many patents that supposedly have value.
Total incompetence and or total frauds. Either way shareholders have been screwed. A miracle is the only chance
Wrong again!! At least 100% consistent
Market Cap Market Cap
4,298,793
07/25/2023
Authorized Shares
250,000,000
09/29/2020
Outstanding Shares
119,080,135
11/09/2022
HGEN was given the same chance and failed. Remember HGEN released its 8k with the potential bankruptcy option. Wake up!!!
Spam? This has zero to do with HGEN
On July 18, 2023, John Hohneker resigned from the Board, and on July 19, 2023 Cheryl Buxton and Kevin Xie both resigned from the Board, in each case with immediate effect. The decisions of Dr. Hohneker, Ms. Buxton and Mr. Xie to resign were not the result of disagreements with Humanigen on any matter relating to Humanigen's operations, policies or practices.
Wow!! No words can define the severe denial of reality. It’s the definition of insanity. LENZ can’t even help
Management is our biggest obstacle!!
For 5 cents a share?
It’s called an 8k
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 18, 2023
Humanigen, Inc.
(Exact name of registrant as specified in its charter)
001-35798
(Commission File No.)
830 Morris Turnpike, 4th Floor
Short Hills, New Jersey 07078
(Address of principal executive offices and zip code)
(973) 200-3010
(Registrant's telephone number, including area code)
Delaware
(State or other Jurisdiction of Incorporation)
77-0557236
(IRS Employer Identification No.)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ WrittencommunicationspursuanttoRule425undertheSecuritiesAct(17CFR230.425)
¨ SolicitingmaterialpursuanttoRule14a-12undertheExchangeAct(17CFR240.14a-12)
¨ Pre-commencementcommunicationspursuanttoRule14d-2(b)undertheExchangeAct(17CFR240.14d-2(b))
¨ Pre-commencementcommunicationspursuanttoRule13e-4(c)undertheExchangeAct(17CFR240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Name of each exchange on which registered Symbol(s)
Common Stock HGEN The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
As a result of the below-reported resignations of three members of the board of directors (the “Board”) of Humanigen, Inc. (the “Company”), the Company notified The Nasdaq Stock Market of the Company’s non-compliance with each of Nasdaq Rule 5605(b)(1), which requires a Nasdaq-listed company to have a board of directors comprised of a majority of independent directors; and Nasdaq Rule 5605(c)(2), which requires a Nasdaq-listed company to have an audit committee of the board of directors comprised of at least three independent directors meeting the eligibility requirements of that Rule.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On July 18, 2023, John Hohneker resigned from the Board, and on July 19, 2023 Cheryl Buxton and Kevin Xie both resigned from the Board, in each case with immediate effect. The decisions of Dr. Hohneker, Ms. Buxton and Mr. Xie to resign were not the result of disagreements with Humanigen on any matter relating to Humanigen's operations, policies or practices.
Item 8.01 Other Events.
Corporate Update
has been unsuccessful in raising debt or equity financing in sufficient amounts and with acceptable terms to fund the Company’s operations going forward.
In light of these developments and the matters discussed above under Item 3.01, on July 21, 2023, the Company notified the Nasdaq Hearings Panel (the “Panel”) that it does not expect to be able to demonstrate compliance with all applicable criteria for listing on The Nasdaq Capital Market by August 21, 2023, including the $1.00 minimum bid price per share requirement set forth in Nasdaq Listing Rule 5550(a)(2) and the $35 million market value of listed securities requirement set forth in Nasdaq Listing Rule 5550(b)(2). As a result, the Company received a letter on the evening of July 24, 2023 indicating that the Panel will delist the shares of the Company
The Company’s negotiations with a privately held biopharmaceutical company relating to a proposed business combination, as disclosed in the Company’s
Quarterly Report on Form 10-Q filed on May 15, 2023, have ended without execution of a definitive agreement. In addition, the Company has been
unsuccessful in its attempt to identify and complete another strategic or equity financing transaction in the first half of 2023 on terms sufficient to enable the
Company to regain compliance with applicable Nasdaq listing requirements within the extended compliance period of August 21, 2023. The Company further
from the Nasdaq Capital Market and trading in the Company shares will be suspended from Wednesday, July 26, 2023.
The shares will commence trading on the OTC Pink Market. The suspension from trading and delisting from the Nasdaq Capital Market likely would adversely
affect the liquidity of the Company’s common stock and its ability to raise additional capital.
In light of the above, and the Company’s limited cash and cash equivalents, the Company anticipates that it will not be able to continue as a going concern and
is exploring all restructuring options, which may include commencing a bankruptcy or other insolvency proceeding sometime in the third quarter of 2023. In
that regard, the Company is evaluating term sheets relating to potential sales of assets in a bankruptcy proceeding. Given the Company’s lack of liquidity, any
such bankruptcy filing may result in a complete or substantial loss of value for holders of our common stock.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit
No. Description
Probably true !!
Almost has traded its total OS shares!! Where are the insiders? Why not use the 10’s of millions they profited from previous sells to save this 10 Trillion $ company !!
Management sucks and should be called on their failures
How old is this news?
Wrong
Complete insanity
Do we close green?
Yes. I’m the idiot of the year for believing in HGEN and not following what they are. I chased. But let’s hope it’s not over yet.